Medicus Sciences Acquisition (MSAC) Annual Balance Sheets

Annual · GAAP · USD millions
Access MSAC quarterly Balance Sheets →
Examining balance sheet movements between Medicus Sciences Acquisition and reveals how Dec 31 2021 adjusts its asset composition and liability profile.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2021)
Assets
Cash & cash equivalent1.43
Cash & Short-term Investments1.00
Due from Related Parties, Current RE0.00
Prepaid Expense, Current AS0.15
Total Current Assets1.58
Other Assets, Noncurrent92.00
Derivative Assets Forward Purchase Agreement0.04
Total Assets93.62
Liabilities
Accrued Liabilities, Current AC0.03
Total Current Liabilities0.03
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE5.94
Other liabilities, Noncurrent2.30
Deferred Underwriting Commissions Noncurrent2.30
Total Liabilities8.27
Stockholders' Equity
Common Stock Value0.00
Retained Earnings / Accumulated Deficit-6.64
Other Equity-92.00
Common Stockholder's Equity-98.64
Non-controlling interests & other92.00
Total Stockholder's Equity-6.64
Liabilities & Stockholder's Equity93.62
4 historic quarters locked

Sign in to unlock the full Medicus Sciences Acquisition balance sheet history.

About Medicus Sciences Acquisition Corp Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-22-118537

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.